|
Volumn 14, Issue 5, 2000, Pages 333-338
|
A phase I trial of andrographolide in HIV positive patients and normal volunteers
|
Author keywords
AIDS; Andrographis paniculata; Andrographolide; CD4+ lymphocytes; HIV 1
|
Indexed keywords
ANDROGRAPHOLIDE;
PN 355;
UNCLASSIFIED DRUG;
ADULT;
ANAPHYLAXIS;
ANDROGRAPHIS PANICULATA;
ARTICLE;
CELL CYCLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
FATIGUE;
FEMALE;
HEADACHE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
MALE;
PHASE 1 CLINICAL TRIAL;
PHYTOTHERAPY;
PRURITUS;
T LYMPHOCYTE;
ADMINISTRATION, ORAL;
ADULT;
ANTIVIRAL AGENTS;
CD4-POSITIVE T-LYMPHOCYTES;
DITERPENES;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
MIDDLE AGED;
PLANTS, MEDICINAL;
REFERENCE VALUES;
RNA, VIRAL;
TREATMENT OUTCOME;
ANDROGRAPHIS PANICULATA;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 0033846074
PISSN: 0951418X
EISSN: None
Source Type: Journal
DOI: 10.1002/1099-1573(200008)14:5<333::AID-PTR584>3.0.CO;2-D Document Type: Article |
Times cited : (369)
|
References (31)
|